A new drug is approved. What’s next?

We finally get to ask that question about lupus, after the FDA approved Benlysta, the first new drug approved for SLE in over 50 years, in March 2011. 

Patients and researchers alike are asking questions …  Who needs to take this drug?  How is it different from the medicines that doctors were already using?  How do we know it’s going to work? How do we know that it’s going to work better than those other medications?






0
Emily Gillespie

About the Author:

Emily Gillespie, Ph.D., is a 2014 and 2015 LFM Lupus Clinical Research Grant recipient whose studies have focused on cardiovascular disease in SLE as well as the relationship between lupus and women, particularly African-American women. She has been researching lupus for over 10 years and enjoys the challenge of trying to understand such a complicated disease. Dr. Gillespie works as a Principal Clinical Evidence Specialist in the Restorative Therapies Group at Medtronic.
  Related Stories

Add a Comment